dc.contributor.author
Marí Almirall, Marta
dc.contributor.author
Cosgaya Castro, Clara
dc.contributor.author
Pitart, Cristina
dc.contributor.author
Viñes, Joaquim
dc.contributor.author
Muñoz López, Laura
dc.contributor.author
Campo, Irene
dc.contributor.author
Cuscó, Anna
dc.contributor.author
Rodríguez Serna, Laura
dc.contributor.author
Santana, Gemina
dc.contributor.author
Río, Ana del
dc.contributor.author
Francino, Olga
dc.contributor.author
Ciruela, Pilar
dc.contributor.author
Pujol, Isabel
dc.contributor.author
Ballester, Frederic
dc.contributor.author
Marco, Francesc
dc.contributor.author
Martínez Hernández, José Alfredo
dc.contributor.author
Soriano Viladomiu, Alex
dc.contributor.author
Vila Estapé, Jordi
dc.contributor.author
Roca Subirà, Ignasi
dc.contributor.author
MERCyCAT Study Group
dc.date.accessioned
2024-11-26T18:54:05Z
dc.date.available
2024-11-26T18:54:05Z
dc.date.issued
2023-12-11T16:13:53Z
dc.date.issued
2023-12-11T16:13:53Z
dc.date.issued
2021-01-19
dc.date.issued
2023-12-11T16:13:53Z
dc.identifier
http://hdl.handle.net/2445/204484
dc.identifier.uri
http://hdl.handle.net/2445/204484
dc.description.abstract
Objectives: To characterize the clonal spread of carbapenem-resistant Klebsiella pneumoniae and Escherichia coli isolates between different healthcare institutions in Catalonia, Spain. Methods: Antimicrobial susceptibility was tested by disc diffusion. MICs were determined by gradient diffusion or broth microdilution. Carbapenemase production was confirmed by lateral flow. PCR and Sanger sequencing were used to identify the allelic variants of resistance genes. Clonality studies were performed by PFGE and MLST. Plasmid typing, conjugation assays, S1-PFGE plus Southern blotting and MinION Oxford Nanopore sequencing were used to characterize resistance plasmids. Results: Twenty-nine carbapenem-resistant isolates recovered from three healthcare institutions between January and November 2016 were included: 14 K. pneumoniae isolates from a tertiary hospital in the south of Catalonia (hospital A); 2 K. pneumoniae isolates from a nearby healthcare centre; and 12 K. pneumoniae isolates and 1 E. coli isolate from a tertiary hospital in Barcelona (hospital B). The majority of isolates were resistant to all antimicrobial agents, except colistin, and all were NDM producers. PFGE identified a major K. pneumoniae clone (n = 27) belonging to ST147 and co-producing NDM-1 and CTX-M-15, with a few isolates also harbouring blaOXA-48. Two sporadic isolates of K. pneumoniae ST307 and E. coli ST167 producing NDM-7 were also identified. blaNDM-1 was carried in two related IncR plasmid populations and blaNDM-7 in a conjugative 50 kb IncX3 plasmid. Conclusions: We report the inter-hospital dissemination of XDR high-risk clones of K. pneumoniae and E. coli associated with the carriage of small, transferable plasmids harbouring blaNDM genes.
dc.format
application/pdf
dc.publisher
Oxford University Press
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1093/jac/dkaa459
dc.relation
Journal of Antimicrobial Chemotherapy, 2021, vol. 76, num.2, p. 345-354
dc.relation
https://doi.org/10.1093/jac/dkaa459
dc.rights
(c) Marí-Almirall M et al., 2021
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Fonaments Clínics)
dc.subject
Escheríchia coli
dc.subject
Medicaments antibacterians
dc.subject
Microbiologia mèdica
dc.subject
Klebsiella pneumoniae
dc.subject
Escherichia coli
dc.subject
Antibacterial agents
dc.subject
Medical microbiology
dc.subject
Klebsiella pneumoniae
dc.title
Dissemination of NDM-producing Klebsiella pneumoniae and Escherichia coli high-risk clones in Catalan healthcare institutions
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion